neurological disorders: the calcium link of heart and mind

1
824 | NOVEMBER 2004 | VOLUME 5 www.nature.com/reviews/neuro RESEARCH HIGHLIGHTS Changes away from the synapse NEUROLOGICAL DISORDERS According to a study published in the Journal of Neuroscience, changes to extrasynaptic GABA (γ- aminobutyric acid) receptors in a mouse model of epilepsy could contribute to overall changes in neural excitability. Peng et al. studied the expression of specific GABA receptor subunits in mice in which epilepsy had been induced by treatment with pilocarpine. GABA receptors that contain the δ-subunit are usually found outside synapses, where they might be tonically active or activated by transmitter spillover from nearby synapses. These extrasynaptic GABA receptors are thought to be important for controlling neuronal excitability, and mutations in the gene for the δ- subunit have been identified in patients with generalized epilepsy. In the mouse model of epilepsy that was used for this study, a single treatment with pilocarpine is used to induce a chronic epileptic condition with spontaneous seizures. The authors monitored changes in the expression of the δ-subunit over the period after the injection. After four days, diffuse immunohistochemical labelling for the δ-subunit was decreased in the molecular layer of the dentate gyrus, but after a week this general decrease in labelling was accompanied by a specific increase in the labelling of interneurons (most of which are inhibitory). These changes were sustained over the 60 days of the study. If excitatory neurons in the dentate gyrus have fewer extrasynaptic GABA receptors, and inhibitory interneurons in the same area have more, this could lead to a decrease in overall inhibition in this area and an increase in the excitability of the neuronal network. To test this, the authors performed electrophysiology on brain slices from the pilocarpine- treated mice. As predicted, these slices were more excitable than those from control mice, and they were also resistant to the normal decrease in excitability caused by treatment with a neurosteroid. These findings point to the potential importance of extrasynaptic GABA receptors in epilepsy, and show that differential changes in receptor expression in interneurons and principal neurons might produce a combined effect on excitability in models of epilepsy. Rachel Jones References and links ORIGINAL RESEARCH PAPER Peng, Z. et al. Altered expression of the δ subunit of the GABA A receptor in a mouse model of temporal lobe epilepsy. J. Neurosci. 24, 8629–8639 (2004) FURTHER READING Semyanov, A. et al. Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci. 27, 262–269 (2004) This splice variant of Ca v 1.2 is expressed in many human adult and fetal tissues including the brain, gas- trointestinal system, lungs, immune system, smooth muscle and testis — a pattern that is consistent with the phe- notypic abnormalities associated with Timothy syndrome. In the brain, it is expressed in regions such as the hippocampus, cerebellum and amyg- dala where abnormalities have been implicated in autism. Splawski and colleagues compared the biophysical properties of the wild- type and mutant Ca v 1.2, which were heterologously expressed in Chinese hamster ovary cells and Xenopus laevis oocytes. The G406R mutation com- pletely abolishes voltage-dependent channel inactivation of Ca v 1.2 and results in persistence of inward Ca 2+ currents in the cell. Computer simula- tion indicates that a prolonged Ca 2+ current in cardiomyocytes might lengthen cardiac action potentials and delay repolarization, which would lead to an increased risk of arrhythmia. As the mutant Ca v 1.2 remains sensitive to calcium channel blockers such as dihydrophyridines, these drugs might be useful for treating Timothy syndrome and autism. These findings hint at a potential mechanism that might underlie autism. Future studies will focus on the genetic analysis of Ca v 1.2 and other calcium channels in the disorder and the potential application of calcium channel blocker therapy. Jane Qiu References and links ORIGINAL RESEARCH PAPER Splawski, I. et al. Ca v 1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004) FURTHER READING Zoghbi, H.Y. Postnatal neurodevelopmental disorders: meeting at the synpase? Science 302, 826–830 (2003) Autism affects 0.5% of children around the world and causes great dis- tress, but little is known about the molecular mechanisms involved in this disorder and no therapy is yet available. Reporting in Cell, Splawski and colleagues implicate abnormal calcium signalling in autism, and highlight the therapeutic potential of calcium channel blockers. The authors characterized the phenotypes and molecular basis of Timothy syndrome — a novel disorder that is associated with condi- tions in multiple organ systems, including lethal arrhythmias, immune deficiency and autism. They dis- covered a de novo missense mutation in a splice variant of the calcium L-type channel, Ca v 1.2, in 13 patients with the syndrome. The mutation, G406R, caused a substitution of glycine with arginine at residue 406. Making sense of smell Neuroscience is already well represented in the list of Nobel Prize laureates, and it was recently announced that the 2004 prize for physiology or medicine has been awarded to Linda Buck and Richard Axel for unlocking the secrets of what the Nobel Assembly described as “the most enigmatic of our senses” — the sense of smell. Buck was a senior postdoctoral fellow in Axel’s laboratory in 1991 when the pair published their seminal paper on the discovery of a family of around 1,000 ‘odorant receptor’ genes. They subsequently became competitors in the race to establish how these receptors are deployed in the detection of over 10,000 different odours — a research effort that gave rise to the concept of a combinatorial olfactory code, which was described by Axel as “the brain…essentially saying something like ‘I’m seeing activity in positions 1, 15, and 54 of the olfactory bulb, which corresponds to odorant receptors 1, 15, and 54, so that must be jasmine’” (Times Online, UK, 4 October). As well as exposing the workings of the olfactory system, this research has contributed substantially to our understanding of the link between olfaction and memory: “how very specific smells — a great red wine, the scent of a lover or even an unfresh clam — can remain embedded in the human brain for years, only to be triggered half a lifetime later by a similar smell” (Times Online). This phenomenon was famously illustrated in “Marcel Proust’s novel Remembrance of Things Past, where the smell and taste of a single madeleine cake triggers a long string of memories” (Discovery Channel, USA, 4 October). When asked what he planned to do next, Axel said: “I’m going to have a cup of coffee” (New York Times, 4 October). Heather Wood IN THE NEWS The calcium link of heart and mind NEUROLOGICAL DISORDERS

Upload: jane

Post on 28-Jul-2016

213 views

Category:

Documents


1 download

TRANSCRIPT

824 | NOVEMBER 2004 | VOLUME 5 www.nature.com/reviews/neuro

R E S E A R C H H I G H L I G H T S

Changes away from the synapse

N E U R O LO G I C A L D I S O R D E R S

According to a study published inthe Journal of Neuroscience, changesto extrasynaptic GABA (γ-aminobutyric acid) receptors in amouse model of epilepsy couldcontribute to overall changes inneural excitability.

Peng et al. studied the expressionof specific GABA receptor subunitsin mice in which epilepsy had beeninduced by treatment withpilocarpine. GABA receptors thatcontain the δ-subunit are usuallyfound outside synapses, where theymight be tonically active oractivated by transmitter spilloverfrom nearby synapses. Theseextrasynaptic GABA receptors arethought to be important forcontrolling neuronal excitability,and mutations in the gene for the δ-subunit have been identified inpatients with generalized epilepsy.

In the mouse model of epilepsythat was used for this study, asingle treatment with pilocarpine

is used to induce a chronicepileptic condition withspontaneous seizures. The authorsmonitored changes in theexpression of the δ-subunit overthe period after the injection. Afterfour days, diffuseimmunohistochemical labellingfor the δ-subunit was decreased inthe molecular layer of the dentategyrus, but after a week this generaldecrease in labelling wasaccompanied by a specific increasein the labelling of interneurons(most of which are inhibitory).These changes were sustained overthe 60 days of the study.

If excitatory neurons in thedentate gyrus have fewerextrasynaptic GABA receptors, andinhibitory interneurons in the samearea have more, this could lead to adecrease in overall inhibition in thisarea and an increase in theexcitability of the neuronalnetwork. To test this, the authors

performed electrophysiology onbrain slices from the pilocarpine-treated mice.As predicted, theseslices were more excitable thanthose from control mice, and theywere also resistant to the normaldecrease in excitability caused bytreatment with a neurosteroid.

These findings point to thepotential importance ofextrasynaptic GABA receptors inepilepsy, and show that differentialchanges in receptor expression ininterneurons and principalneurons might produce acombined effect on excitability inmodels of epilepsy.

Rachel Jones

References and linksORIGINAL RESEARCH PAPER Peng, Z. et al.Altered expression of the δ subunit of theGABAA receptor in a mouse model of temporallobe epilepsy. J. Neurosci. 24, 8629–8639(2004)FURTHER READING Semyanov, A. et al.Tonically active GABAA receptors: modulatinggain and maintaining the tone. TrendsNeurosci. 27, 262–269 (2004)

This splice variant of Cav1.2 is

expressed in many human adult andfetal tissues including the brain, gas-trointestinal system, lungs, immunesystem, smooth muscle and testis — apattern that is consistent with the phe-notypic abnormalities associated withTimothy syndrome. In the brain, it is expressed in regions such as thehippocampus, cerebellum and amyg-dala where abnormalities have beenimplicated in autism.

Splawski and colleagues comparedthe biophysical properties of the wild-type and mutant Ca

v1.2, which were

heterologously expressed in Chinesehamster ovary cells and Xenopus laevisoocytes. The G406R mutation com-pletely abolishes voltage-dependentchannel inactivation of Ca

v1.2 and

results in persistence of inward Ca2+

currents in the cell. Computer simula-tion indicates that a prolonged Ca2+

current in cardiomyocytes mightlengthen cardiac action potentials anddelay repolarization, which would leadto an increased risk of arrhythmia.As the mutant Ca

v1.2 remains sensitive

to calcium channel blockers such as dihydrophyridines, these drugsmight be useful for treating Timothysyndrome and autism.

These findings hint at a potentialmechanism that might underlieautism. Future studies will focus onthe genetic analysis of Ca

v1.2 and

other calcium channels in the disorderand the potential application ofcalcium channel blocker therapy.

Jane QiuReferences and links

ORIGINAL RESEARCH PAPER Splawski, I. et al.Cav1.2 calcium channel dysfunction causes amultisystem disorder including arrhythmia andautism. Cell 119, 19–31 (2004)FURTHER READING Zoghbi, H.Y. Postnatalneurodevelopmental disorders: meeting at thesynpase? Science 302, 826–830 (2003)

Autism affects 0.5% of childrenaround the world and causes great dis-tress, but little is known about themolecular mechanisms involved inthis disorder and no therapy is yetavailable. Reporting in Cell, Splawskiand colleagues implicate abnormalcalcium signalling in autism, andhighlight the therapeutic potential ofcalcium channel blockers.

The authors characterized thephenotypes and molecular basis of Timothy syndrome — a novel disorder that is associated with condi-tions in multiple organ systems,including lethal arrhythmias, immunedeficiency and autism. They dis-covered a de novo missense mutationin a splice variant of the calcium L-type channel, Ca

v1.2, in 13 patients

with the syndrome. The mutation,G406R, caused a substitution ofglycine with arginine at residue 406.

Making sense of smellNeuroscience is already wellrepresented in the list of NobelPrize laureates, and it wasrecently announced that the2004 prize for physiology ormedicine has been awardedto Linda Buck and RichardAxel for unlocking the secretsof what the Nobel Assemblydescribed as “the mostenigmatic of our senses” —the sense of smell.

Buck was a seniorpostdoctoral fellow in Axel’slaboratory in 1991 when thepair published their seminalpaper on the discovery of afamily of around 1,000‘odorant receptor’ genes.They subsequently becamecompetitors in the race toestablish how thesereceptors are deployed in thedetection of over 10,000different odours — aresearch effort that gave riseto the concept of acombinatorial olfactory code,which was described by Axelas “the brain…essentiallysaying something like ‘I’mseeing activity in positions 1,15, and 54 of the olfactorybulb, which corresponds toodorant receptors 1, 15, and54, so that must be jasmine’”(Times Online, UK, 4October).

As well as exposing theworkings of the olfactorysystem, this research hascontributed substantially toour understanding of the linkbetween olfaction andmemory: “how very specificsmells — a great red wine,the scent of a lover or even anunfresh clam — can remainembedded in the humanbrain for years, only to betriggered half a lifetime laterby a similar smell” (TimesOnline). This phenomenonwas famously illustrated in“Marcel Proust’s novelRemembrance of ThingsPast, where the smell andtaste of a single madeleinecake triggers a long string ofmemories” (DiscoveryChannel, USA, 4 October).

When asked what heplanned to do next, Axelsaid: “I’m going to have acup of coffee” (New YorkTimes, 4 October).

Heather Wood

IN THE NEWS

The calcium link of heart and mind

N E U R O LO G I C A L D I S O R D E R S